382 related articles for article (PubMed ID: 26507467)
1. Multitarget Strategy to Address Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based Derivatives.
Montanari S; Bartolini M; Neviani P; Belluti F; Gobbi S; Pruccoli L; Tarozzi A; Falchi F; Andrisano V; Miszta P; Cavalli A; Filipek S; Bisi A; Rampa A
ChemMedChem; 2016 Jun; 11(12):1296-308. PubMed ID: 26507467
[TBL] [Abstract][Full Text] [Related]
2. 3-Aryl Coumarin Derivatives Bearing Aminoalkoxy Moiety as Multi-Target-Directed Ligands against Alzheimer's Disease.
Abdshahzadeh H; Golshani M; Nadri H; Saberi Kia I; Abdolahi Z; Forootanfar H; Ameri A; Tüylü Küçükkılınç T; Ayazgok B; Jalili-Baleh L; Sadat Ebrahimi SE; Moghimi S; Haririan I; Khoobi M; Foroumadi A
Chem Biodivers; 2019 May; 16(5):e1800436. PubMed ID: 30957958
[TBL] [Abstract][Full Text] [Related]
3. Targeting Alzheimer's disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238.
Rizzo S; Bartolini M; Ceccarini L; Piazzi L; Gobbi S; Cavalli A; Recanatini M; Andrisano V; Rampa A
Bioorg Med Chem; 2010 Mar; 18(5):1749-60. PubMed ID: 20171894
[TBL] [Abstract][Full Text] [Related]
4. 3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer's disease therapy.
Piazzi L; Rampa A; Bisi A; Gobbi S; Belluti F; Cavalli A; Bartolini M; Andrisano V; Valenti P; Recanatini M
J Med Chem; 2003 Jun; 46(12):2279-82. PubMed ID: 12773032
[TBL] [Abstract][Full Text] [Related]
5. Multiple Ligands Targeting Cholinesterases and β-Amyloid: Synthesis, Biological Evaluation of Heterodimeric Compounds with Benzylamine Pharmacophore.
Szałaj N; Bajda M; Dudek K; Brus B; Gobec S; Malawska B
Arch Pharm (Weinheim); 2015 Aug; 348(8):556-63. PubMed ID: 26032855
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, Biological Evaluation, and Molecular Docking of 8-imino-2-oxo-2H,8H-pyrano[2,3-f]chromene Analogs: New Dual AChE Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease.
Shaik JB; Palaka BK; Penumala M; Eadlapalli S; Darla Mark M; Ampasala DR; Vadde R; Amooru Gangaiah D
Chem Biol Drug Des; 2016 Jul; 88(1):43-53. PubMed ID: 26833890
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Potent Dual Binding Site Acetylcholinesterase Inhibitors via Homo- and Heterodimerization of Coumarin-Based Moieties.
Pisani L; Catto M; De Palma A; Farina R; Cellamare S; Altomare CD
ChemMedChem; 2017 Aug; 12(16):1349-1358. PubMed ID: 28570763
[TBL] [Abstract][Full Text] [Related]
8. The bivalent ligand approach as a tool for improving the in vitro anti-Alzheimer multitarget profile of dimebon.
Rosini M; Simoni E; Bartolini M; Soriano E; Marco-Contelles J; Andrisano V; Monti B; Windisch M; Hutter-Paier B; McClymont DW; Mellor IR; Bolognesi ML
ChemMedChem; 2013 Aug; 8(8):1276-81. PubMed ID: 23824986
[No Abstract] [Full Text] [Related]
9. Design and synthesis of novel coumarin derivatives as potential acetylcholinesterase inhibitors for Alzheimer's disease.
Amin KM; Abdel Rahman DE; Abdelrasheed Allam H; El-Zoheiry HH
Bioorg Chem; 2021 May; 110():104792. PubMed ID: 33799178
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
Bolea I; Juárez-Jiménez J; de Los Ríos C; Chioua M; Pouplana R; Luque FJ; Unzeta M; Marco-Contelles J; Samadi A
J Med Chem; 2011 Dec; 54(24):8251-70. PubMed ID: 22023459
[TBL] [Abstract][Full Text] [Related]
11. Extensive SAR and computational studies of 3-{4-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2H-2-chromenone (AP2238) derivatives.
Piazzi L; Cavalli A; Belluti F; Bisi A; Gobbi S; Rizzo S; Bartolini M; Andrisano V; Recanatini M; Rampa A
J Med Chem; 2007 Aug; 50(17):4250-4. PubMed ID: 17655212
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase.
Catto M; Pisani L; Leonetti F; Nicolotti O; Pesce P; Stefanachi A; Cellamare S; Carotti A
Bioorg Med Chem; 2013 Jan; 21(1):146-52. PubMed ID: 23199476
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship studies of benzyl-, phenethyl-, and pyridyl-substituted tetrahydroacridin-9-amines as multitargeting agents to treat Alzheimer's disease.
Osman W; Mohamed T; Sit VM; Vasefi MS; Beazely MA; Rao PP
Chem Biol Drug Des; 2016 Nov; 88(5):710-723. PubMed ID: 27282589
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer's disease.
Li RS; Wang XB; Hu XJ; Kong LY
Bioorg Med Chem Lett; 2013 May; 23(9):2636-41. PubMed ID: 23511019
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
Shaik JB; Palaka BK; Penumala M; Kotapati KV; Devineni SR; Eadlapalli S; Darla MM; Ampasala DR; Vadde R; Amooru GD
Eur J Med Chem; 2016 Jan; 107():219-32. PubMed ID: 26588065
[TBL] [Abstract][Full Text] [Related]
16. Design and Synthesis of Novel Arylisoxazole-Chromenone Carboxamides: Investigation of Biological Activities Associated with Alzheimer's Disease.
Saeedi M; Rastegari A; Hariri R; Mirfazli SS; Mahdavi M; Edraki N; Firuzi O; Akbarzadeh T
Chem Biodivers; 2020 May; 17(5):e1900746. PubMed ID: 32154628
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and screening of triazolopyrimidine scaffold as multi-functional agents for Alzheimer's disease therapies.
Kumar J; Meena P; Singh A; Jameel E; Maqbool M; Mobashir M; Shandilya A; Tiwari M; Hoda N; Jayaram B
Eur J Med Chem; 2016 Aug; 119():260-77. PubMed ID: 27227482
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological activity of multifunctional α,β-unsaturated carbonyl scaffolds for Alzheimer's disease.
Bag S; Ghosh S; Tulsan R; Sood A; Zhou W; Schifone C; Foster M; LeVine H; Török B; Török M
Bioorg Med Chem Lett; 2013 May; 23(9):2614-8. PubMed ID: 23540646
[TBL] [Abstract][Full Text] [Related]
19. Isoxazolotacrines as non-toxic and selective butyrylcholinesterase inhibitors for Alzheimer's disease.
Cherif O; Allouche F; Chabchoub F; Chioua M; Soriano E; Yañez M; Cacabelos R; Romero A; López MG; Marco-Contelles J
Future Med Chem; 2014; 6(17):1883-91. PubMed ID: 25495982
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of 4-arylcoumarins as potential anti-Alzheimer's disease agents.
Yun Y; Yang J; Miao Y; Wang X; Sun J
Bioorg Med Chem Lett; 2020 Feb; 30(4):126900. PubMed ID: 31882295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
